Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Expert Review of Respiratory Medicine
|
February 26, 2011
Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy
Delphine Carmier, Elisabeth Diot, Patrice Diot
La Revue Du Praticien
|
November 4, 2014
[Interstitial lung disease in connective tissue disorders]
Delphine Carmier, Élisabeth Diot, Laurent Guilleminault, et al.
Anticancer Research
|
January 31, 2012
Metastatic renal cell carcinoma treated sequentially with multiple VEGF receptor-targeted inhibitors--a case report
Claude Linassier, Delphine Carmier, Pierre Combe, et al.
Cancers
|
May 14, 2022
<i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?
Xavier Cansouline, Béatrice Lipan, Damien Sizaret, et al.
Cancers
|
May 14, 2025
Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification
Xavier Cansouline, Abdelhakim Elmraki, Béatrice Lipan, et al.
Targeted Oncology
|
July 15, 2018
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries
Marion Ferreira, Eric Pichon, Delphine Carmier, et al.
ERJ Open Research
|
December 1, 2022
1-year mortality in lung cancer in France according to key timepoints of care pathways
Axelle Rivière, Anne Isabelle Lecuyer, Emeline Laurent, et al.
Journal of Pain and Symptom Management
|
February 24, 2020
Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer
François Chaumier, Thomas Flament, Thierry Lecomte, et al.
Journal of Clinical Medicine
|
December 2, 2020
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
Guillaume Herbreteau, Alexandra Langlais, Laurent Greillier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 22, 2019
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial
Jean-Louis Pujol, Laurent Greillier, Clarisse Audigier-Valette, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Expert Review of Respiratory Medicine
|
February 26, 2011
Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy
Delphine Carmier, Elisabeth Diot, Patrice Diot
La Revue Du Praticien
|
November 4, 2014
[Interstitial lung disease in connective tissue disorders]
Delphine Carmier, Élisabeth Diot, Laurent Guilleminault, et al.
Anticancer Research
|
January 31, 2012
Metastatic renal cell carcinoma treated sequentially with multiple VEGF receptor-targeted inhibitors--a case report
Claude Linassier, Delphine Carmier, Pierre Combe, et al.
Cancers
|
May 14, 2022
<i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?
Xavier Cansouline, Béatrice Lipan, Damien Sizaret, et al.
Cancers
|
May 14, 2025
Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification
Xavier Cansouline, Abdelhakim Elmraki, Béatrice Lipan, et al.
Targeted Oncology
|
July 15, 2018
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries
Marion Ferreira, Eric Pichon, Delphine Carmier, et al.
ERJ Open Research
|
December 1, 2022
1-year mortality in lung cancer in France according to key timepoints of care pathways
Axelle Rivière, Anne Isabelle Lecuyer, Emeline Laurent, et al.
Journal of Pain and Symptom Management
|
February 24, 2020
Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer
François Chaumier, Thomas Flament, Thierry Lecomte, et al.
Journal of Clinical Medicine
|
December 2, 2020
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
Guillaume Herbreteau, Alexandra Langlais, Laurent Greillier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 22, 2019
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial
Jean-Louis Pujol, Laurent Greillier, Clarisse Audigier-Valette, et al.
Page
of 2